Peptides for the Treatment of HCV Infections
This invention relates to novel compounds that are peptides derivatives and pharmaceutically acceptable salts thereof. More specifically, this invention relates to novel peptides that are deuterated derivatives of boceprevir. This invention also provides compositions comprising one or more compounds...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
27.09.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to novel compounds that are peptides derivatives and pharmaceutically acceptable salts thereof. More specifically, this invention relates to novel peptides that are deuterated derivatives of boceprevir. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating HCV infection. |
---|---|
Bibliography: | Application Number: US201013321785 |